What is the standard of care for managing pain in adult patients?

Standard of Care for Pain Management in Adults

The WHO three-step analgesic ladder remains the foundational framework for pain management, progressing from non-opioids (acetaminophen/NSAIDs) for mild pain, to weak opioids for moderate pain, to strong opioids for severe pain, with regular dosing schedules and oral administration as first-line route 1, 2.

Core Principles

The standard approach requires five essential elements 1:

• Oral drug administration whenever possible
• Regular scheduled dosing (not "as needed" for chronic pain)
• Stepwise progression following the WHO ladder based on pain intensity
• Individualized titration to balance pain relief against side effects
• Proactive management of breakthrough pain and adverse effects

Assessment Requirements

Pain assessment must be systematic and ongoing 2:

• Use validated scales (NRS, VAS, or VRS) for intensity measurement
• Classify pain type: nociceptive (somatic/visceral from tissue damage) vs neuropathic (nerve damage/dysfunction)
• Document temporal patterns, triggers, relieving factors, and functional impact
• Assess interference with daily activities, sleep, mood, and quality of life
• Screen for psychological comorbidities and substance abuse risk

Critical caveat: One-dimensional numerical pain scales alone are insufficient and have been associated with increased adverse events when used as sole treatment guides 3. Clinical assessment of sedation level and function is mandatory.

Treatment Algorithm by Pain Severity

Mild Pain (WHO Step 1)

First-line: Acetaminophen 1g every 4-6 hours (maximum 4g/day) 1

• Monitor hepatic function; use cautiously in liver disease
• NSAIDs for inflammatory/bone pain (ibuprofen up to 3200mg/day in divided doses) 4
• Contraindications for NSAIDs: concurrent methotrexate, high bleeding risk, renal dysfunction, cardiovascular disease 1, 4
• COX-2 inhibitors carry thrombotic cardiovascular risks without reducing renal toxicity 2

Moderate Pain (Opioid-Naïve Patients)

Start with short-acting opioids 5:

• Morphine 5mg solution or 7.5mg immediate-release oral
• Hydromorphone 2mg oral
• Oxycodone 2.5-5mg ± acetaminophen 325mg
• Hydrocodone 5mg + acetaminophen 325mg

Titration strategy: Increase daily dose by 30-100% until pain relief achieved 5. If multiple daily doses consistently needed, add long-acting formulation based on total daily requirement.

Severe Pain (WHO Step 3)

Strong opioids are indicated immediately for severe pain—do not delay by stepping through the ladder 1

• Morphine remains the gold standard
• Alternatives: hydromorphone, oxycodone, fentanyl patches (for stable pain only)
• Rescue doses: 10% of total daily opioid dose, can repeat hourly up to 4 times before reassessment 1
• No ceiling dose for pure agonist opioids if side effects controlled 1

Route Selection

Oral route is standard 2. Alternative routes only when:

• Severe vomiting/bowel obstruction
• Severe dysphagia or confusion
• Poor pain control requiring rapid escalation
• Intolerable oral opioid side effects

Critical Safety Measures

Never abruptly discontinue opioids 1. Taper by 30-50% weekly increments, monitoring for pain recurrence or withdrawal.

Avoid combining two drugs from same class with same kinetics (e.g., two sustained-release opioids) 1

Monitor sedation level continuously—94% of opioid oversedation events are preceded by decreased consciousness 3

Adjuvant Therapies

Co-analgesics can be used at any WHO ladder step 1:

• Neuropathic pain: anticonvulsants, antidepressants
• Bone pain: NSAIDs, bisphosphonates, radiation
• Inflammatory pain: corticosteroids

Documentation and Follow-up

Written treatment plans must specify 1, 4:

• Each medication with dosing schedule and purpose
• Breakthrough pain management protocol
• Expected side effects and management strategies
• Contact numbers for problems (uncontrolled pain, no bowel movement ×3 days, excessive sedation, confusion)
• Medications to discontinue

Re-evaluate at every patient contact 2, 5. Adjust therapy based on pain intensity, functional status, and adverse effects.

Common Pitfalls

• Relying solely on numerical pain scores without clinical assessment of sedation and function 3
• Delaying strong opioids in severe pain by rigidly following the ladder
• Using NSAIDs long-term without monitoring renal, GI, and cardiovascular toxicity 4, 2
• Prescribing opioids "as needed" for chronic pain instead of scheduled dosing
• Failing to anticipate and prevent constipation with opioid therapy
• Inadequate rescue medication availability for breakthrough pain